本发明提供的是一种治疗乙肝的中药。
The invention provides a Chinese medicine for curing hepatitis B.
其中一类的干扰素常被用来治疗乙肝或丙肝感染。
One class of interferons is used to treat chronic infection with HBV and HCV.
临床上常用于治疗乙肝、丙肝、癌症和免疫缺陷等疾病。
Clinically, it is often used to treat hepatitis B, hepatitis c, cancer and immune deficiency diseases.
结论拉米夫定辅助治疗乙肝肝硬化效果理想，值得临床推广使用。
Conclusion The adjuvant treatment of liver cirrhosis with lamivudine results are satisfactory, is worthy of clinical use.
我的医生给我用的PEG-干扰素目前还没有被通过作为治疗乙肝的药物。
I am currently taking PEG Interferon for Hep B but it's just something that my Doctor is doing and it is not officially approved for Hep B.
目的研究中药制剂达美施乙肝三号治疗乙肝后肝纤维化、肝硬化的治疗效果及安全性。
Objective To evaluate the efficiency and safety of "TINMAX" HB-3 Herbal Compound (cpd) in treatment of hepatofibrosis and cirrhosis post chronic hepatitis B.
目前，全世界多数国家用于治疗乙肝的药物为抗干扰素，但是其低的有效率(30- 40%)和昂贵的治疗费用及副作用限制了其应用。
Presently, the drug of treating HBV is interferon in most countries, but low efficiency (30-40%), high treatment expenditure and side effect limit its application.
为了解决个人和公众的健康问题，急需进行试验以便寻找既能有效治疗乙肝又不会诱导各种adap -VEM出现的现有药物的最佳组合。
To address individual and public health concerns, trials are urgently needed to find the optimal combination of existing drugs that are effective but do not induce the emergence of ADAP-VEMs.
据估计，20- 30%的乙肝病毒感染者能够从治疗中获益。
It is estimated that 20-30% of persons with HBV infection could benefit from treatment.
1998年首个核苷类似物药物拉米夫定推出之前，慢性乙肝病毒感染者可选的有效治疗途径一直都非常有限。
Effective treatment options for individuals with chronic hepatitis B infection were limited until 1998 when lamivudine, the first nucleoside analogue drug, was introduced.
乙肝病毒感染治疗已被证明能够降低肝癌和死亡风险。
Treatment of HBV infection has been shown to reduce the risk of liver cancer and death.
我在临床上接触过不少患者，往往得了乙肝以后，一种心态就是不重视，认为现在没什么不舒服，可以不治疗，不去管它。
I contacted many patients with clinically, often got second liver later, a state of mind is not value, think now nothing uncomfortable, can not treated, never mind it.
目的探讨乙肝病毒免疫标志物与HBV - DNA之间的相互关系，为临床诊断和治疗提供有价值的判断标准。
Objective To explore the correlation between the immune markers of HBV and HBV-DNA for the diagnosis and treatment of hepatitis b.
在慢乙肝的治疗方面，它们的应用情况如何？
What are their applications in treatment of chronic hepatitis B?
方法应用超声多普勒系统测量18例经自体LAK细胞回输治疗的慢乙肝患者治疗前后门静脉血流动力学参数。
Methods The changes of portal hemodynamics were measured by using ultrasonic Doppler system in 18 patients with CHB before and after treatment with self LAK cell infusion.
这些才是乙肝是否需要治疗的真正指标。
These are the real need treatment hepatitis b whether index.
患者在接受治疗前应该检查潜在肺结核，乙肝，和艾滋病感染。
Patients should be screened for latent tuberculosis, hepatitis b, and HIV infection before beginning therapy.
应用新型基因芯片研究乙肝病毒多点基因变异在慢性乙肝患者中的意义，为临床诊断和治疗提供依据。
ObjectiveTo study clinical meaning of new DNA chip technique in detecting the mutation of HBV-DNA , and to offer testimony for clinical diagnosis and treatment.
抗病毒治疗应扩大到慢性乙肝和轻度丙氨酸转氨酶升高的患者吗？
Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
《国际肝病》：乙肝治疗的耐药性已经成为一个世界性问题。您能否介绍一下在新加坡如何解决耐药性问题？
Hepatology Digest: The treatment of HBV drug resistance is becoming an emerging worldwide problem. Would you like to share with us your experience treating HBV resistance in Singapore?
目的评估唾液乙肝DNA检测在乙型肝炎的诊断及治疗方面的意义。
Objective To evaluate the clinic implication of hepatitis B virus DNA in saliva for diagnosis and treatment.
结果中西医对慢性乙肝的认识和治疗，进行了积极的探讨，且中医药有独特的优势。
Results: traditional medicine and western medicine have explored positively about CHB, and the traditional medicine has made unique progress.
有的患者问医生我的乙肝病毒怎样治疗？
Some of my patients asked the doctor how the treatment of hepatitis B virus?
《国际肝病》：乙肝治疗的耐药性已经成为一个世界性问题。
Hepatology Digest: The treatment of HBV drug resistance is becoming an emerging worldwide problem.
结论：拉米夫定治疗慢性乙肝及乙肝病毒携带者安全有效。
Conclusion: Lamivudin is efficient and safe medicine in the treatment of CHB and HBV carrier.
结论中医药治疗慢性乙肝疗效好，值得推广。
Conclusion: The traditional medicine has positive effect on CHB, it is worth spreading.
中医辨证治疗能有效地调节慢性乙肝湿热蕴脾证患者的CD细胞功能。
Treatment according to TCM differentiation can availably regulate the function of CD cells in CHB with DH.
《国际肝病》：对于评估慢乙肝治疗和预后的最重要指标是什么？
Ask: which is the most important index of evaluating CHB treatment and outcome?
《国际肝病》：对于评估慢乙肝治疗和预后的最重要指标是什么？
Ask: which is the most important index of evaluating CHB treatment and outcome?
应用推荐